Inventor
Sophie Perrin-Ninkovic
Inventor
La Jolla, CA, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium15%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%
PatentTitleYear
10,683,298Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors202010,167,290Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors20199,771,371'Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors'20179,193,692'Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors'20159,079,900'Methods of synthesis and purification of heteroaryl compounds'20158,907,087'Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors'20148,569,494'Methods of synthesis and purification of heteroaryl compounds'20138,507,492'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway'20138,492,381'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway'20138,372,976'Methods of treatment comprising the administration of heteroaryl compounds'20138,110,578'Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway'20127,981,893'Heteroaryl compounds, compositions thereof, and methods of treatment therewith'20117,589,119'Methods for treating or preventing metastatic cancer using benzopyranone compounds'20097,358,274'Methods for treating or preventing cancer using Benzopyranone Compounds'20087,091,235'Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2020Patents assigned to SIGNAL PHARM LLC (14)· patent assignee history
2006–2013Based in Carlsbad, CA, US· patent location history
2012–2013Patents assigned to PERRIN-NINKOVIC SOPHIE (5)· patent assignee history
2012–2013Patents assigned to ELSNER JAN (4)· patent assignee history
2012–2013Patents assigned to HARRIS ROY L (4)· patent assignee history
2012–2013Patents assigned to MORTENSEN DEBORAH (4)· patent assignee history
2012–2020Based in La Jolla, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SIGNAL PHARM LLC | 14 | 2006–2020 |
| PERRIN-NINKOVIC SOPHIEself | 5 | 2012–2013 |
| ELSNER JAN | 4 | 2012–2013 |
| HARRIS ROY L | 4 | 2012–2013 |
| MORTENSEN DEBORAH | 4 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| La Jolla, California, US | 10 | 2012–2020 |
| Carlsbad, California, US | 5 | 2006–2013 |